Best in Biotech 28 Jan 2026 Seven Italian biotechs to know about in 2026 Delve into Italy’s biotech landscape with seven companies that are leading the charge in the European country. January 28, 2026 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 27 Jan 2026 How the University of North Carolina at Chapel Hill is enhancing RNAi potency with its new technology Discover how a newly developed platform technology from The University of North Carolina at Chapel Hill can enhance RNAi potency. January 27, 2026 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 26 Jan 2026 A clearer path to relief: sinusitis treatments on the way Emerging sinusitis treatments include monoclonal antibodies to tackle the unmet medical needs of patients. January 26, 2026 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Webinars Produced by Inpart 26 Jan 2026Partnering trends and predictions 2026 A data-driven discussion on biopharma partnering trends, exploring dealmaking signals, AI-driven collaboration, and new approaches to R&D and BD landscaping shaping 2026. January 26, 2026 Share WhatsApp Twitter Linkedin Email Produced by Inpart
In Depth 23 Jan 2026 What does 2026 hold for the biotech industry? Delve into what 2026 has to offer in the biotech industry. The market is showing signs it’s picking up and the patent cliff is driving deals. January 23, 2026 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 23 Jan 2026Top 5 trends that will drive biopharma in the next decade with Tim Opler Today, we’re thrilled to have Tim Opler, a leading voice in biotech investment banking. January 23, 2026 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 21 Jan 2026 Could CRISPR really cure these diseases? Here are some of the diseases that scientists aim to tackle using CRISPR technology, testing its possibilities and limits as a medical tool. January 21, 2026 - 16 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 20 Jan 2026 Hepatitis B: Are we edging closer to a cure? Find out whether we are closing in on a cure for hepatitis B – a virus affecting the liver that can cause acute and chronic disease. January 20, 2026 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Sponsored by WittKieffer 20 Jan 2026 From science to scale: building biotech companies via milestone leadership Explore how leadership in biotech drives success through a milestone approach, aligning teams and culture from science to scale. January 20, 2026 - 10 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Jan 2026 Curing ALS? Ten companies developing new treatments in 2026 Delve into the increasingly dynamic landscape of ALS treatment development with ten companies advancing candidates in 2026. January 19, 2026 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Whitepapers 19 Jan 2026Robust lentiviral manufacturing platforms in the age of accessible cell therapy Discover how lentiviral platforms and ready-to-deploy CAR-T solutions are overcoming barriers of global access to life-saving cures. January 19, 2026 Share WhatsApp Twitter Linkedin Email
More News! 16 Jan 2026 JPM 2026: what’s the outlook like this year? This year, JPM 2026 took place again in San Francisco. Let’s look at predictions and trends forecast for 2026, according to attendees at JPM. January 16, 2026 - 13 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email